Browsing by Author Marc Peeters

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerГотько, Євген Степанович; Marc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerMarc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Yevhen Hotko; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland; Gregory Wilson; Tudor-Eliade Ciuleanu; Laslo Roman; Eric Van Cutsem; Ying Tian; Andre Scott Jung; Roger Sidhu; Scott D. Patterson
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Готько, Євген Степанович; Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Yevhen Hotko; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2014-05-20Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).Готько, Євген Степанович; Marc Peeters; Kelly Smith Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis JA Punt; Andrew Strickland; Gregory Wilson
2014-05-20Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).Marc Peeters; Kelly Smith Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Yevhen Hotko; Thierry Andre; Emily Chan; Florian Lordick; Cornelis JA Punt; Andrew Strickland; Gregory Wilson; Tudor E Ciuleanu